| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/07/2009 | CN101336975A Traditional Chinese medicine ointment for treating dermatophytosis |
| 01/07/2009 | CN101336958A Use of alkaloids extracted from sophora flavescens in preparing medicine for treating diseased reduced by mycoplasma, chlamydia and fungus |
| 01/07/2009 | CN101336957A Strong Dikang oral liquid |
| 01/07/2009 | CN101336952A Pus drawing-out paste for treating local inflammation and preparation method thereof |
| 01/07/2009 | CN101336944A Xiaoxingzhang eye instant gel |
| 01/07/2009 | CN101336940A Thalassia hemprichii extract and preparation method and use thereof |
| 01/07/2009 | CN101336938A Use of probiotics in preparing composition for treating and preventing hand-foot-mouth disease |
| 01/07/2009 | CN101336910A Chlorhexidine composition with colouring function |
| 01/07/2009 | CN101336903A Preparation method of (s)-ornidazole disodium phosphate intravenous preparation for injection |
| 01/07/2009 | CN101336888A External medicament for treating onychomycosis |
| 01/07/2009 | CN101336637A Complex type broad-spectrum disinfectant and use thereof |
| 01/07/2009 | CN100448994C Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof |
| 01/07/2009 | CN100448879C Method for preparing unformed cefuroxime axetil |
| 01/07/2009 | CN100448482C Freeze dried HGF preparations |
| 01/07/2009 | CN100448472C Chinese medicinal formulation for treating pulmonary tuberculosis |
| 01/07/2009 | CN100448464C Synergistic medicinal composition for treating hepatitis |
| 01/07/2009 | CN100448463C Synergistic medicinal composition containing diammonium glycyrrhizicnate and Chinese medicine |
| 01/07/2009 | CN100448459C Synergistic medicine composition for treating hepatitis |
| 01/07/2009 | CN100448451C Nutritional compositions with contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions |
| 01/07/2009 | CN100448444C Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors |
| 01/07/2009 | CN100448443C Nanometer antifungal econazole nitrate emulsion medicine and its prepn process |
| 01/07/2009 | CN100448433C Clarithromycin enteric medicinal composition |
| 01/07/2009 | CN100448431C Oral disintegrated Anfenmame tablet for treating children's cold and its prepn |
| 01/06/2009 | US7473790 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 01/06/2009 | US7473779 e.g. 2-amino-N-(4-{[amino(2-thienyl)methylidene]amino}phenethyl)-5-methoxybenzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 01/06/2009 | US7473762 solid phase synthesis; for diagnosis/treatment/prophyaxis; animal models; genetic engineering |
| 01/06/2009 | US7473761 Therapy for metabolic disorders; polycystic kidney diseasel diarrhea; gastrointestinal disorders |
| 01/06/2009 | US7473703 e.g. N-(4-{1-Hydroxy-1-[1-(2-methoxyethyl)-1H-pyrrol-2-yl]-ethyl}-phenyl)-N-methyl-benzenesulfonamide; liver X receptor (LXR) agonist; antidiabetic, antiproliferative agent; lipid, metabolic disorders, obesity, diabetes, hypercholesterolemia, atherosclerosis, hyperlipoproteinemia |
| 01/06/2009 | US7473699 antibiotic; Gram-positive pathogens (Staphylococci, Enterococci, and Streptococci ), MRSA and MRCNS; resistance to vancomycin and E. faecium to both aminoglycosides and beta--lactams; gram negative strains H.influenzae, M.catarrhalis and chlamydia; improved activity against mono-amine oxidase (MAO) |
| 01/06/2009 | US7473688 Indolobenzazepine HCV NS5B inhibitors |
| 01/06/2009 | US7473433 Pulmonary delivery of polyene antifungal agents |
| 01/06/2009 | US7473428 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus |
| 01/06/2009 | US7473424 Comprises immunoglobulin for use in diagnosis, prevention and treatment of hemorrhagic viral infection; viricides and immunotherapy |
| 01/06/2009 | US7473247 Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 01/06/2009 | CA2457642C Crystalline forms of ertapenem sodium |
| 01/06/2009 | CA2414737C Pharmaceutical compositions containing tobramycin and xanthan gum |
| 01/06/2009 | CA2400818C Antibiotic and antifungal compositions |
| 01/06/2009 | CA2391297C 6-o-alkyl-2-nor-2-substituted ketolide derivatives |
| 01/06/2009 | CA2380231C Conditionally controlled, attenuated hiv vaccine |
| 01/06/2009 | CA2369504C Pyrazole compositions useful as inhibitors of erk |
| 01/06/2009 | CA2339174C Aminosterol compounds and uses thereof |
| 01/06/2009 | CA2309353C Surfactant-based antimicrobial compositions and methods for using same |
| 01/06/2009 | CA2305341C Stabilization of envelope glycoprotein trimers by disulfide bonds introduced into a gp41 glycoprotein ectodomain |
| 01/06/2009 | CA2268138C Mycosis vaccines |
| 01/06/2009 | CA2266409C Mouthwash comprising calcium and phosphate ions in supersaturated solution |
| 01/06/2009 | CA2245584C Recombinant expression of s-layer proteins |
| 01/06/2009 | CA2181590C Peptomers with enhanced immunogenicity |
| 01/06/2009 | CA2117490C Purified vacuolating toxin from helicobacter pylori and methods to use same |
| 01/06/2009 | CA1341588C Human ifn-beta2/i1-6, its purification and use |
| 01/02/2009 | DE60224401T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure |
| 01/02/2009 | DE102007030103A1 Verwendung einer synergistischen Zusammensetzung als therapeutisches oder kosmetisches Mittel Use of a synergistic composition as a therapeutic or cosmetic agent |
| 01/01/2009 | US20090005580 Compounds, compositions and methods |
| 01/01/2009 | US20090005461 Use of Cannabidiol in the Treatment of Hepatitis |
| 01/01/2009 | US20090005454 Method of Reducing Nosocomial Infections |
| 01/01/2009 | US20090005453 Crystalline forms of tigecycline and processes for preparation thereof |
| 01/01/2009 | US20090005452 Diphenyl Urea Derivatives |
| 01/01/2009 | US20090005448 Injection for Mastitis |
| 01/01/2009 | US20090005422 Bacterial thioredoxin reductase inhibitors and methods for use thereof |
| 01/01/2009 | US20090005387 Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors |
| 01/01/2009 | US20090005385 Treatment or Prevention of Cancer or Cardiovascular Disease with Methenyltetrahydrofolate Synthetases |
| 01/01/2009 | US20090005371 Substituted Fused [1,2]Imidazo[4,5-C] Ring Compounds and Methods |
| 01/01/2009 | US20090005368 such as 6-({trans-4-[(1R)-1-hydroxy-2-(3-methoxy-quinolin-5-yl)-ethyl]-cyclohexylamino}-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one for treating infections from Streptococcus pneumoniae, Haemophilus influenzae, Moraxella, Staphylococcus, Enterococcus |
| 01/01/2009 | US20090005351 Hormone replacement therapy |
| 01/01/2009 | US20090005346 Azacytosine Derivatives Useful as Antiviral Agents |
| 01/01/2009 | US20090005343 B-cyclodextrin derivatives and their use against anthrax lethal toxin |
| 01/01/2009 | US20090005338 Carbonyl-substituted titanocenes |
| 01/01/2009 | US20090005335 Compounds for the modulation of beta-catenin expression |
| 01/01/2009 | US20090005334 Nucleic acid derivatives |
| 01/01/2009 | US20090005332 Compositions and Methods for Modulating Gene Expression Using Self-Protected Oligonucleotides |
| 01/01/2009 | US20090005326 Single dose roxithromycin |
| 01/01/2009 | US20090005325 Ketolide Derivatives as Antibacterial Agents |
| 01/01/2009 | US20090005308 activins (ActRIIB), for modulating (promoting or inhibiting) growth of tissue such as bone, cartilage, muscle, fat, and/or neuronal tissue; fusion proteins which inhibit signaling by myostatin and/or growth differentiation factor 11 in cell-based assay; drug screening; pharmacokinetics |
| 01/01/2009 | US20090005305 Service for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using crt translocation |
| 01/01/2009 | US20090005300 Antimicrobial Peptides and Methods of Use |
| 01/01/2009 | US20090004722 bovine parainfluenza virus (bPIV) cDNA or RNA which may be used to express heterologous gene products; tumor antigens; cancer |
| 01/01/2009 | US20090004296 Antiseptic Compositions and Methods of Using Same |
| 01/01/2009 | US20090004295 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 01/01/2009 | US20090004294 Personal lubricant formulations comprising colloidal metals and methods of use |
| 01/01/2009 | US20090004251 Bacteriocins and Novel Bacterial Strains |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004227 Peroral Vaccine Carrier System |
| 01/01/2009 | US20090004226 Fusion proteins of mycobacterium tuberculosis |
| 01/01/2009 | US20090004222 Influenza Vaccination |
| 01/01/2009 | US20090004217 for determining whether an animal is naturally-infected with Ehrlichia canis, or is either not infected or is vaccinated with an E. canis vaccine |
| 01/01/2009 | US20090004216 inducing an immunological response in an animal by administering to the animal an attenuated CSFV pestivirus, wherein the RNase activity of glycoprotein ERNS of the CSFV pestivirus is inactivated by a deletion of the second histidine of the conserved ERNS sequence RHEWNKHGWCNW |
| 01/01/2009 | US20090004215 Chimeric G protein based rabies vaccine |
| 01/01/2009 | US20090004209 4'-O- substituted isoindoline derivatives and compositions comprising and methods of using the same |
| 01/01/2009 | US20090004204 Assays and methods using biomarkers |
| 01/01/2009 | US20090004203 Methods of treating measles infectious disease in mammals |
| 01/01/2009 | US20090004201 Therapy-Enhancing Glucan |
| 01/01/2009 | US20090004198 Human monoclonal antibody binding to human cytomegalovirus and its antigen binding portion |
| 01/01/2009 | US20090004194 Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity |
| 01/01/2009 | US20090004188 antibody that specifically binds to a human TNF Receptor in the BRAIN (TRAIN) polypeptide; useful in regulating cell differentiation, death, and survival |
| 01/01/2009 | US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE |
| 01/01/2009 | US20090004146 Humanised Baculovirus |
| 01/01/2009 | US20090004143 Treatment of diseases caused by viral infection |
| 01/01/2009 | US20090004141 Broad spectrum immune and antiviral gene modulation by oral interferon |
| 01/01/2009 | US20090004140 4-substituted pyrrolidine as anti-infectives |
| 01/01/2009 | US20090004139 Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly |
| 01/01/2009 | US20090004138 Bicyclic Nucleosides and Nucleotides as Therapeutic Agents |